Prealbumin

"Prealbumin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.

Descriptor ID	D011228
MeSH Number(s)	D12.776.034.841.450 D12.776.124.727.750
Concept/Terms	Prealbumin Prealbumin Transthyretin Proalbumin

Below are MeSH descriptors whose meaning is more general than "Prealbumin".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Albumins [D12.776.034]
Serum Albumin [D12.776.034.841]
Prealbumin [D12.776.034.841.450]
Blood Proteins [D12.776.124]
Serum Albumin [D12.776.124.727]
Prealbumin [D12.776.124.727.750]

Below are MeSH descriptors whose meaning is related to "Prealbumin".

Below are MeSH descriptors whose meaning is more specific than "Prealbumin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prealbumin" by people in this website by year, and whether "Prealbumin" was a major or minor topic of these publications.

Bar chart showing 14 publications over 11 distinct years, with a maximum of 3 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	1	1
2007	0	1	1
2008	1	0	1
2010	1	0	1
2011	0	1	1
2013	1	0	1
2014	1	0	1
2021	0	1	1
2022	0	3	3
2023	0	2	2
2024	0	1	1

Below are the most recent publications written about "Prealbumin" by people in Profiles.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, Gonz?lez-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. N Engl J Med. 2025 01 02; 392(1):33-44.

View in: PubMed
Vijayakumar S, Pabon AR, Clerc OF, Cuddy SAM, Gu Y, Watts C, Sullivan K, Auer B, Kijewski MF, DiCarli MF, Falk RH, Dorbala S. Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy. J Nucl Cardiol. 2024 Sep; 39:102019.

View in: PubMed
Auer B, Kijewski MF, Dorbala S. Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now! J Nucl Cardiol. 2023 06; 30(3):1246-1249.

View in: PubMed
Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS. Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure. Curr Probl Cardiol. 2023 Jun; 48(6):101667.

View in: PubMed
Rowin EJ, Ruberg FL, Das G, Higgins D, Lipe WC, Bokhari N, Dehn M, Maron BJ, Maron MS. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2022 12; 15(12):e014938.

View in: PubMed
Prokaeva T, Klimtchuk ES, Feschenko P, Spencer B, Cui H, Burks EJ, Aslebagh R, Muneeruddin K, Shaffer SA, Varghese E, Berk JL, Connors LH. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis. Amyloid. 2023 Jun; 30(2):141-152.

View in: PubMed
Kaku MC, Bhadola S, Berk JL, Sanchorawala V, Connors LH, Lau KHV. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays. Amyloid. 2022 Sep; 29(3):184-189.

View in: PubMed
Batista AR, Flotte TR. In?vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis. Mol Ther. 2021 09 01; 29(9):2633-2634.

View in: PubMed
Batista AR, Gianni D, Ventosa M, Coelho AV, Almeida MR, Sena-Esteves M, Saraiva MJ. Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model. Gene Ther. 2014 Dec; 21(12):1041-50.

View in: PubMed
Batista AR, Sena-Esteves M, Saraiva MJ. Hepatic production of transthyretin L12P leads to intracellular lysosomal aggregates in a new somatic transgenic mouse model. Biochim Biophys Acta. 2013 Aug; 1832(8):1183-93.

View in: PubMed

People

Explore

Similar Concepts

Top Journals